The drugmaker Regeneron Pharmaceuticals has agreed to buy the genetic testing firm 23andMe Holding for $256m through a bankruptcy auction, the companies announced on Monday. Regeneron said it will comply …
wikdaily 2025. Designed and Developed by Pro